Last reviewed · How we verify

NCT07022054

iCare IC1000 Alignment Study

Completed NA Last updated 12 August 2025
What this trial tests

NA trial testing iCare IC1000 measurement in Intraocular Pressure in 100 participants. Completed in 5 August 2025.

Timeline
22 May 2025
Primary endpoint
5 August 2025
5 August 2025

Quick facts

Lead sponsorIcare Finland Oy
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment100
Start date22 May 2025
Primary completion5 August 2025
Estimated completion5 August 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Icare Finland Oy

Who can join

18 and older, any sex, with Intraocular Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to evaluate the performance of the alignment feature of iCare IC1000 tonometer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intraocular Pressure

Currently open trials in the same condition.

Other Icare Finland Oy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07022054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing